Zealand Pharma A/S (ZLDPY) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for Zealand Pharma A/S (ZLDPY).

Download OTCGems on Google Play Download OTCGems on the App Store

Equity Overview

Price & Market Data

Price: $12.86

Daily Change: $0.00 / 0.00%

Range: $0 - $0

Market Cap: $0

Volume: 0

Performance Metrics

1 Week: 10.20%

1 Month: -79.09%

3 Months: -79.13%

6 Months: -79.13%

1 Year: -79.13%

YTD: -79.13%

Details

Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States. The company has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. It also provides Zegalogue, a single use syringe or autoinjector for the treatment of severe hypoglycemia; and Dasiglucagon bi-hormone artificial pancreas systems containing insulin and dasiglucagon. Its pipeline includes Dasiglucagon for treating congenital hyperinsulinism. In addition, the company developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. Zealand Pharma A/S was incorporated in 1997 and is based in Søborg, Denmark.

Selected stocks

NU E Power Corp. (NUEPF)

Enagas S.A. (ENGGY)

Azure Power Global Limited (AZREF)